首页> 外文期刊>Bone marrow transplantation >Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
【24h】

Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.

机译:同种异体造血干细胞受体中树突状细胞嵌合和T细胞嵌合的动力学。

获取原文
获取原文并翻译 | 示例
       

摘要

Dendritic cells (DC) as potent antigen-presenting cells (APC) and T cells as effector cells play an essential role in the pathophysiology of both graft-versus-host (GvH) and graft-versus-leukemia (GvL) reactions after transplantation. Therefore, we determined the kinetics of DC and T-cell chimerism establishment after allogeneic hematopoietic cell transplantation (AHCT) in a group of 144 patients, using fluorescence-activated cell sorting (FACS) or magnetic cell sorting (MACS) followed by FISH or STR-PCR analysis for chimerism evaluation. In all, three cell lines investigated (CD3(+) T cells, CD11c(+) DC1 and CD123(+) DC2), we found a rapid and consistent establishment of complete donor chimerism (CDC) in over 70% of all patients during the first 6 weeks after AHCT. The rate of patients with CDC increased significantly over time within the first year after transplantation. A related donor (P=0.004) as well as an underlying lymphatic leukemia (P=0.03) were found to be significantly associated with development of MC in T cells. No significant correlation between DC or T cell chimerism and GvHD or relapse was detected. Our results thus demonstrate a fast and stable CDC in DC1, DC2 and T cells after AHCT that continuously increases over time in nearly all patients.
机译:树突状细胞(DC)作为有效的抗原呈递细胞(APC)和T细胞作为效应细胞在移植后的移植物抗宿主(GvH)和移植物抗白血病(GvL)反应的病理生理中起着至关重要的作用。因此,我们使用荧光激活细胞分选(FACS)或磁性细胞分选(MACS),然后进行FISH或STR,确定了144位患者的异基因造血细胞移植(AHCT)后DC和T细胞嵌合体建立的动力学。 -PCR分析,进行嵌合度评估。总之,我们调查了三种细胞系(CD3(+)T细胞,CD11c(+)DC1和CD123(+)DC2),发现在此期间有超过70%的患者快速而一致地建立了完整的供体嵌合(CDC)。 AHCT之后的前6周。移植后第一年内,CDC患者的比率随时间显着增加。发现相关的供体(P = 0.004)和潜在的淋巴性白血病(P = 0.03)与T细胞中MC的发展显着相关。在DC或T细胞嵌合体与GvHD或复发之间未发现显着相关性。因此,我们的结果证明了AHCT后DC1,DC2和T细胞中快速稳定的CDC随时间推移在几乎所有患者中不断增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号